Puma has failed in its bid for leave to appeal a decision that found its ‘Procat’ trade mark was deceptively similar to US machinery manufacturer Caterpillar’s CAT marks.
The maker of Finish dishwashing products has had two of its trade marks struck from the register after losing an intellectual property suit against an emerging rival.
A Full Federal Court judge has questioned whether law firm Maurice Blackburn was “savvy” to the origins of New York’s famous Fearless Girl statue when it launched a copycat marketing campaign in Melbourne’s Federation Square.
The maker of Somat dishwashing products has hit back at allegations of trade mark infringement, telling a court the prominent brand name on its range of dishwashing tablets functions as an “unmistakable” point of difference between the company and market leader Finish.
The Full Federal Court has upheld US biotech company Sequenom’s patent for a noninvasive prenatal genetic test, rejecting rival Ariosa Diagnostic’s argument that the patent merely described a way to extract incorporeal genetic information.
A top intellectual property barrister who has worked on cutting-edge cases that raise novel questions about the patentability of inventions has been appointed to the Federal Court.
The Federal Court is set to determine whether artificial intelligence can be the inventor of a patent, after an AI pioneer filed a challenge to an IP Australia finding that allowing a machine to be considered an inventor would render the Patents Act incapable of “sensible operation”.
Ariosa Diagnostics is fighting to revoke a patent for noninvasive prenatal test owned by Sequenom, arguing it merely describes how to extract “incorporeal” genetic information that is naturally found within the DNA of an unborn foetus.
Australian drug maker InterPharma will not appeal a ruling that dismissed its challenge to the validity of global pharmaceutical giant Pfizer’s patent for sedative drug Precedex.
A court has found Ariosa Diagnostics infringed a patent held by Sequenom for a noninvasive prenatal genetic test, and ruled one claim of the patent invalid for lack of fair basis.